Clinical Trials Directory

Trials / Recruiting

RecruitingNCT02099734

Germ Cell Tumor and Testicular Tumor DNA Registry

Status
Recruiting
Phase
Study type
Observational
Enrollment
1,000 (estimated)
Sponsor
Memorial Sloan Kettering Cancer Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study is being done to create a registry to help us learn more about germ cell tumors (GCT) and other testicular tumors. The registry will include people with these tumors and also relatives and unrelated people without these tumors. This study will help us learn more about the prevention, diagnosis, treatment and outcome of these tumors. Studying relatives of patients and people unrelated to patients with GCT and other testicular tumors will help us understand why some people get these tumors and why some people don't.

Conditions

Interventions

TypeNameDescription
BEHAVIORALQuestionnaires
OTHERsample of blood or salivaA sample of blood or saliva will be obtained for DNA extraction. Approximately 2-4 tubes of blood will be collected or one tablespoon of saliva. If a participant has already provided a DNA sample for another MSKCC IRB approved protocol, they may not need to provide an additional sample.

Timeline

Start date
2014-01-01
Primary completion
2028-01-01
Completion
2028-01-01
First posted
2014-03-31
Last updated
2026-02-04

Locations

8 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02099734. Inclusion in this directory is not an endorsement.